吳 思遠

Medicine & Life Sciences

1. Propensity Score 100%
2. Cohort Studies 99%
3. Chemoradiotherapy 99%
4. Radiotherapy 82%
5. Intensity-Modulated Radiotherapy 69%
6. Neoplasms 58%
7. Population 56%
8. Survival 54%
9. Adenocarcinoma 53%
10. Hydroxymethylglutaryl-CoA Reductase Inhibitors 48%
11. Confidence Intervals 47%
12. Squamous Cell Carcinoma 47%
13. Squamous Cell Carcinoma of Head and Neck 39%
14. Comorbidity 35%
15. Mortality 35%
16. Neoplasm Metastasis 33%
17. Breast Neoplasms 33%
18. fucoidan 30%
19. Therapeutics 30%
20. Esophageal Squamous Cell Carcinoma 28%
21. Hepatocellular Carcinoma 28%
22. Adenocarcinoma of Lung 27%
23. Drug Therapy 26%
24. Regression Analysis 25%
25. Head and Neck Neoplasms 25%
26. Databases 25%
27. Adjuvant Radiotherapy 24%
28. Chronic Obstructive Pulmonary Disease 24%
29. Recurrence 23%
30. ErbB Receptors 23%
31. Mouth 22%
32. Prostatic Neoplasms 22%
33. Thorax 22%
34. Human Influenza 22%
35. Registries 22%
36. Induced Hyperthermia 22%
37. Colon 21%
38. Mastication 20%
39. MicroRNAs 20%
40. Colonic Neoplasms 20%
41. Vaccination 19%
42. Prostatectomy 18%
43. Sutton disease 2 18%
44. Image-Guided Radiotherapy 18%
45. Simple Mastectomy 17%
46. Elderly 17%
47. Survival Rate 17%
48. Lung 17%
49. Radiation Pneumonitis 16%
50. Apoptosis 16%